Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Theravance, Inc.”

369 pharma patents match "Theravance, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 369
Index total 30,257
Page 3 / 16

Quick answer

This filtered view shows 369 pharmaceutical patents matching "Theravance, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

369 results for “Theravance, Inc.” · 30,257 patents in full index Clear search

  1. US 8471040

    Serotonin reuptake inhibitors

    Theravance, Inc. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  2. US 8455530

    Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Theravance, Inc. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  3. US 8455665

    3-phenoxymethylpyrrolidine compounds

    Theravance, Inc. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  4. US 8450362

    Amidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  5. US 8449890

    Neprilysin inhibitors

    Theravance, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  6. US 8404711

    5-HT4 receptor agonist compounds for treatment of cognitive disorders

    Theravance, Inc. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  7. US 8399488

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  8. US 8399501

    Crystalline alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid and methods for preparing thereof

    Theravance, Inc. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  9. US 8394846

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  10. US 8383669

    Crystalline form of a 3-phenoxymethylpyrrolidine compound

    Theravance, Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted

  11. US 8377964

    Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted

  12. US 8377965

    Crystalline forms of a biphenyl compound

    Theravance, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted

  13. US 8378121

    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted

  14. US 8377966

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted

  15. US 8372984

    Dual-acting oxazole antihypertensive agents

    Theravance, Inc. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted

  16. US 8362060

    Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Theravance, Inc. · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  17. US 8349875

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  18. US 8350027

    Dual-acting pyrazole antihypertensive agents

    Theravance, Inc. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  19. US 8344013

    Dual-acting imidazole antihypertensive agents

    Theravance, Inc. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted

  20. US 8338418

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  21. US 8338424

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  22. US 8329911

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  23. US 8324236

    Crystalline forms of a 3-carboxypropyl-aminotetralin compound

    Theravance, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  24. US 8318765

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.